Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study
Novartis
Novartis
Athenex, Inc.
Atara Biotherapeutics
Novartis
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Morphotek
Cellerant Therapeutics
INSYS Therapeutics Inc
Novartis
Enzon Pharmaceuticals, Inc.
MedImmune LLC